Since the regulatory role of HoxA9 in cardiac hypertrophy was uncertain, gain-of-function and loss-of-function experiments were designed to investigate the effect of HoxA9 in NRCMs. The gene discussed is HOXA9; the disease is cardiac hypertrophy.